Catheter Precision - VTAK Net Assets per Single Share

Revenue growth is driving the promotion of the VidiPlan system for precise arrhythmia mapping for Catheter Precision (VTAK). Robotic installations that lock clinics into the service provide a stable income stream. However, reliance on third-party catheter assembly plants creates operational risks. The book value per share metric visualizes tangible assets net of debt, with the 4.91 level representing the current value of this indicator.

Accounting Value of a Share: Catheter Precision Inc (VTAK) for 02/21/2024 - 10/05/2026

catheterprecision.com - analytical breakdowns and key metrics (VTAK)

- price and consensus price forecast:
Stock Price Catheter Precision Corp|VTAK - Analyst Consensus Forecast
- market capitalization data:
Market Value Catheter Precision, Inc.|VTAK - Enterprise Value
- book capitalization data:
Book Value per Share Catheter Precision|VTAK - Accounting Value of Company|Market Capitalization to Book Value Ratio catheterprecision.com|VTAK - Company Assets
- debt and liquidity data:
Total Debt to Capital Catheter Precision|VTAK - Long-Term Debt to Capital|Short-Term Debt to Equity Catheter Precision, Inc.|VTAK - Aggregate Debt Obligations|Debt to Book Value Catheter Precision, Inc.
Initial company analysis:VTAK (Catheter Precision Corp)

For Catheter Precision (VTAK), maintaining significant component inventories in the US directly impacts net asset value, reflecting the material base required for uninterrupted production. By analyzing the current book value per share, an investor can see the remaining capital after all liabilities are settled, allowing for an assessment of the business's real intrinsic value and its level of protection against market risks.

Competitors of Catheter Precision (VTAK)

Regeneron Inc. - Book Value per Share|IRTC: Book Value per Share|LNTH: Net Assets per Single Share|mineralystx.com (MLYS) - Book Value per Share|HTFL - Book Value per Share|Accounting Value of a Share Kestra Medical Technologies, Inc.|Esperion Therapeutics Inc - Book Value per Share|Net Asset Value per Share Amarin Pharma (AMRN)|Book Value per Share AVR (Anteris Technologies)|Tenaya - Book Value per Share|Net Assets per Single Share CVRx (CVRX)|Milestone Pharmaceuticals, Inc. (MIST) - Accounting Value of a Share|CRDL - Accounting Value per Share|HeartBeam Corporation (BEAT) - Book Price of a Share|Book Value per Share TENX|Accounting Value per Share adagiomedical.com|Book Value per Share BCDA|Book Value per Share arcabio.com ABIO|Accounting Value per Share Acasti Pharma Inc. (ACST)|Book Price of a Share Aerovate Therapeutics, Inc AVTE|Book Value per Share Verve (VERV)|WINT - Accounting Value of a Share